The FEI was first established in 1922 and today it overlooks the operations and tackles the barriers facing the entire Industrial Sector. This is achieved through 16 dynamic, highly active Chambers and 12 Decision Support Committees that are constantly developing programs and services to facilitate and support the various industries within Egypt.
The FEI is home to 16 Industrial Chambers that represent the most active sectors within the Egyptian Business Community.
The Chambers act as the strategic organizational entity which labors restlessly in order to enhance the performance and productivity of the Sector members in addition to providing tools that facilitate the overall commercial and business effectiveness.
Twelve committees comprised of a forceful assortment of carefully selected, highly proficient members who have demonstrated an impressive track record of success within their respective business and industrial sectors.
The committees function as the energy that fuels the persistent force by which the FEI boldly tackles all the barriers facing the Egyptian Industrial Sectors.
Contact
26A Sherif Street, Imobilia Building, Downtown, Cairo
Tel.: (+202) 23937270
WEBSITE :http://www.fei.org.eg/index.php/en/chambers-en/651-pharmaceutical-cosmetics-appliances-chamber-ar
The latest news from Egyptian healthcare and life sciences, including progress towards the launch of a massive new oncology hospital, why local manufacturer EIPICO is expanding into Kazakhstan, increased governmental…
Amgen has forged a solid position as one of the world’s largest independent biotechnology companies. With a market capitalisation of some USD 130 billion and 27 approved medicines, the US-based…
There have been both ups and downs in AbbVie’s recent history. After proving its staying power with the celebration of its 10-year anniversary as an independent company spun off from…
Head of the Middle East region and GM for the Middle East & Africa affiliate, Basel Thaher outlines his 18-year career at Menarini and discusses the Italian family-run company’s footprint…
Speaking as GM and head of the Middle East, Turkey, and Africa region, Andrew Bird, who has since become Acino’s Interim Chief Executive Officer, discusses the Swiss company’s “being global…
GSK has undergone a number of changes in recent years. After driving a major transformation that began in 2017 to strengthen its R&D performance, the British multinational suffered the impact…
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
The memorandum of understanding includes the localization of manufacturing at EVA Pharma’s specialized and internationally accredited facility for the manufacture of immunosuppressants in the 10th of Ramadan City, Egypt, in…
Amira Younes of AbbVie UAE examines how the COVID-19 pandemic highlighted the need for new ways of thinking about delivering regulatory effectiveness and efficiency in the region, and for flexibility…
The Middle East and Africa (MEA), the fifth-largest regional pharma market in the world, is rapidly becoming a pharmaceutical powerhouse with both global and local firms taking advantage of the…
Barely four and a half years ago, Egyptian President Abdel Fattah el-Sisi secured overwhelming re-election vowing to “place public health front and centre” of a radical reform and stabilization agenda.…
Diabetes is a significant, and growing, problem in Africa, making access to insulin products a regional imperative. Some important progress is being made, including a new deal between US giant…
See our Cookie Privacy Policy Here
